According to study findings, primary care providers were more likely to prescribe opioids later in the day or if they were behind schedule.
As the country tries to not only address the consequences of the opioid epidemic but also gain a better understanding of opioid-prescribing behaviors, a new study is suggesting that the time of an appointment could influence a provider's decision to prescribe an opioid.
Published in JAMA Network Open, the study findings show that providers are more likely to prescribe opioids later in the day. They also found that if a provider was behind schedule, they were more likely to write the prescription.
“These findings support the widespread perception among providers that time pressure to provide a ‘quick fix’ is one reason why opioids are frequently prescribed in the United States,” Hannah Neprash, assistant professor in the School of Public Health at the University of Minnesota, said in a statement. “If similar patterns exist in other clinical scenarios, such as managing challenging chronic illness, this phenomenon could have relevance for public health and quality improvement efforts.”
As the day progressed, there was a 33% relative increase in opioid prescribing among 5603 primary care doctors seeing more than 600,000 opioid-naïve patients complaining of a painful condition in 2017.
Compared with the first and third appointments of the day, providers were more likely to prescribe patients opioids during the nineteenth and twenty-first appointments of the day (5.3% vs 4.0%).
“Although the absolute difference in prescribing rate across the day of 1.3 percentage points is modest, it is similar in magnitude to the 0.9% absolute reduction in monthly incidence of initial opioid prescribing that occurred nationwide from 2012 to 2017, a period when overall opioid prescription volume decreased substantially in the United States,” noted the researchers, adding that the finding suggests a change of this magnitude could have “meaningful relevance for national trends in opioid use.”
According to the researchers, if rates of opioid prescribing during the first 3 appointments had stayed consistent throughout the day, there would have been 4459 fewer prescriptions that year.
Running late also increased the chances of an opioid prescription, with prescriptions increasing from 4.4% for appointments starting on time to 9 minutes late to 5.2% for appointments running at least an hour late. This represented a 17% relative increase in opioid prescriptions.
In contrast, these patterns in increased prescribing were not seen when looking at nonsteroidal anti-inflammatory drug prescriptions or physical therapy referrals.
The findings, according to the researchers, have several implications for understanding provider decision making and quality measurement, including that “even within individual physicians, clinical decision-making can be meaningfully influenced by external factors.”
They added that interventions to better standardize sensitive treatment decisions, including shared decision-making tools, could minimize the impact of these external factors.
Reference
Neprash H, Barnett M. Association of primary care clinic appointment time with opioid prescribing [published online August 30, 2019]. JAMA Netw Open. doi:10.1001/jamanetworkopen.2019.10373.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More